Firdapse for Post-BOTOX Vocal Weakness

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

October 28, 2021

Primary Completion Date

May 27, 2025

Study Completion Date

September 23, 2025

Conditions

Vocal Weakness(Post-BOTOX Injection)

Interventions

DRUG

Amifampridine

10mg tablet

Trial Locations (1)

Augusta University, Augusta

All Listed Sponsors

lead

Augusta University

OTHER

NCT05123053 - Firdapse for Post-BOTOX Vocal Weakness | Biotech Hunter | Biotech Hunter